Enanta Pharmaceuticals | Aktywa

Assets Zmiana Data
Amgen USD 97.15B 6.62B 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Incyte USD 6.78B 393.87M 2023-12
Insmed USD 1.33B 4.96M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Enanta Pharmaceuticals Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2024.